NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1030220360

Registered date:05/10/2022

MDS-NMS TRANSLATION PROGRAM

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedparkinson's disease
Date of first enrollment08/06/2022
Target sample size300
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeConfirmatory factors for the 9 domains of MDS-NMS
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderBoth
Include criteriaPatients whose native language is Japanese Patients diagnosed with Parkinson's disease according to the International Parkinson and Movement Disorder Society's Parkinson's Disease Diagnostic Criteria 2015 Patients who are able to obtain written consent for participation in the study of their own free will after receiving a thorough explanation of their participation in the study. Patients between the ages of 20 and 79 years old Any gender
Exclude criteriaPatients with serious underlying diseases or complications that make it difficult for the attending physician to make an evaluation decision. Other patients who are deemed inappropriate as research subjects by the principal investigator.

Related Information

Contact

Public contact
Name Matsuzaki Yoshiyuki
Address 10F. Toranomon 33 Mori Building 3-8-21 Toranomon, Minato-ku, Tokyo Tokyo Japan 105-0001
Telephone +81-3-4362-4500
E-mail MDS-NMS_validation-study@mebix.co.jp
Affiliation Mebix Inc.
Scientific contact
Name Oyama Genko
Address 2-1-1 Hongo, Bunkyo-ku, Tokyo Tokyo Japan 113-8431
Telephone +81-3-3813-3111
E-mail g_oyama@juntendo.ac.jp
Affiliation Neurology, Juntendo University